Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)

China flag China · Delayed Price · Currency is CNY
29.14
+0.73 (2.57%)
At close: Mar 10, 2026
0.07%
Market Cap 3.69B
Revenue (ttm) 367.49M
Net Income (ttm) -47.39M
Shares Out 126.54M
EPS (ttm) -0.40
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,813,749
Average Volume 2,087,279
Open 28.42
Previous Close 28.41
Day's Range 28.42 - 29.47
52-Week Range 23.20 - 41.50
Beta -0.79
RSI 45.80
Earnings Date Mar 28, 2026

About SHE:301089

Tuoxin Pharmaceutical Group Co.,Ltd. engages in the research and development, production and sales of nucleoside (acid) APIs and pharmaceutical intermediates in China. It offers nucleoside (acid) products, such as pyrimidine series, purine series, and nucleotide series; nucleoside series, including citicoline sodium, ribavirin, inosine, acyclovir, azithromycin, cytosine, 5-fluorocytosine, cytidine, uridine; and other APIs and pharmaceutical intermediates covering antiviral, anti-tumor, and nervous system. The company was founded in 2001 and is ... [Read more]

Sector Healthcare
Founded 2001
Employees 1,551
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301089
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.